You are here: Home » News-CM » Companies » Results
Business Standard

Combat Drugs standalone net profit declines 8.33% in the September 2018 quarter

Capital Market 

Sales rise 504.55% to Rs 1.33 crore

Net profit of Combat Drugs declined 8.33% to Rs 0.11 crore in the quarter ended September 2018 as against Rs 0.12 crore during the previous quarter ended September 2017. Sales rose 504.55% to Rs 1.33 crore in the quarter ended September 2018 as against Rs 0.22 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales1.330.22 505 OPM %7.5254.55 -PBDT0.110.12 -8 PBT0.110.12 -8 NP0.110.12 -8

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, November 19 2018. 09:33 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU